SteelPeak Wealth’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$518K Sell
7,505
-704
-9% -$48.6K 0.02% 345
2025
Q1
$578K Buy
8,209
+408
+5% +$28.7K 0.02% 312
2024
Q4
$671K Buy
7,801
+3,220
+70% +$277K 0.03% 284
2024
Q3
$545K Buy
4,581
+84
+2% +$10K 0.02% 293
2024
Q2
$642K Sell
4,497
-419
-9% -$59.8K 0.03% 267
2024
Q1
$636K Buy
4,916
+690
+16% +$89.2K 0.03% 261
2023
Q4
$437K Sell
4,226
-500
-11% -$51.7K 0.03% 283
2023
Q3
$430K Buy
4,726
+50
+1% +$4.55K 0.03% 265
2023
Q2
$378K Buy
4,676
+1,002
+27% +$81.1K 0.02% 278
2023
Q1
$295K Hold
3,674
0.02% 295
2022
Q4
$249K Buy
+3,674
New +$249K 0.02% 329
2022
Q3
Sell
-4,302
Closed -$240K 413
2022
Q2
$240K Hold
4,302
0.02% 352
2022
Q1
$239K Buy
4,302
+246
+6% +$13.7K 0.01% 359
2021
Q4
$227K Buy
+4,056
New +$227K 0.01% 355